Glykind-M Tablets ? Gliclazide & Metformin Hydrochloride | Oral Antidiabetic by Mankind / Discovery

?? Product Description

Glykind-M is a combination oral antidiabetic medication containing Gliclazide and Metformin Hydrochloride, designed for effective blood sugar control in type 2 diabetes mellitus. Manufactured by Mankind Pharma (Discovery), this formulation helps improve glycemic control in adults whose diabetes is not adequately managed by diet, exercise, or single-drug therapy.

This dual-therapy tablet combines:

• Gliclazide: A sulfonylurea that increases insulin secretion

• Metformin: A biguanide that reduces hepatic glucose production and improves insulin sensitivity

?? Dosage & Administration

• Active Ingredients:

  • Gliclazide (dosage as per variant, typically 80 mg or modified-release 60 mg)

  • Metformin Hydrochloride (usually 500 mg or 1000 mg)

• Form: Oral tablets

• Frequency: As prescribed by a healthcare professional, usually 1?2 times daily

• Best Taken: With meals to reduce gastrointestinal side effects

?? Packaging Details

• Brand: Glykind-M

• Manufacturer: Mankind Pharma (Discovery Division)

• Pack Size: 12 strips ? 10 tablets (120 tablets total)

• Packaging Type: Blister strip

?? Mechanism of Action

• Gliclazide stimulates insulin secretion from pancreatic ?-cells

• Metformin decreases liver glucose production and increases insulin sensitivity

Together, they offer a complementary mechanism to effectively manage type 2 diabetes.